Armata Pharmaceuticals (ARMP) EBIT (2016 - 2026)
Quarterly results put EBIT at -$8.8 million for Q1 2026, down 7.25% from a year ago — trailing twelve months through Mar 2026 was -$37.2 million (up 7.85% YoY), and the annual figure for FY2025 was -$36.6 million, up 13.67%.
Armata Pharmaceuticals has reported EBIT over the past 14 years, most recently at -$8.8 million for Q1 2026.
- EBIT reached -$8.8 million in Q1 2026 per ARMP's latest filing, up from -$13.8 million in the prior quarter.
- Across five years, EBIT topped out at -$6.8 million in Q2 2025 and bottomed at -$13.8 million in Q4 2025.
- Median EBIT over the past 5 years was -$9.6 million (2023), compared with a mean of -$9.7 million.
- The largest annual shift saw EBIT crashed 70.77% in 2022 before it soared 42.55% in 2025.
- Over 5 years, EBIT stood at -$10.3 million in 2022, then rose by 7.25% to -$9.6 million in 2023, then dropped by 10.02% to -$10.5 million in 2024, then tumbled by 31.16% to -$13.8 million in 2025, then skyrocketed by 36.45% to -$8.8 million in 2026.
- Business Quant data shows EBIT for ARMP at -$8.8 million in Q1 2026, -$13.8 million in Q4 2025, and -$7.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -2.97 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -19.70 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -15.76 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 1.14 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 642.90 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | -3.82 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 268.64 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | -8.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.79 Mn |
| Dec 31, 2025 | -13.82 Mn |
| Sep 30, 2025 | -7.78 Mn |
| Jun 30, 2025 | -6.84 Mn |
| Mar 31, 2025 | -8.19 Mn |
| Dec 31, 2024 | -10.54 Mn |
| Sep 30, 2024 | -9.76 Mn |
| Jun 30, 2024 | -11.91 Mn |
| Mar 31, 2024 | -10.23 Mn |
| Dec 31, 2023 | -9.58 Mn |
| Sep 30, 2023 | -10.34 Mn |
| Jun 30, 2023 | -9.63 Mn |
| Mar 31, 2023 | -11.35 Mn |
| Dec 31, 2022 | -10.33 Mn |
| Sep 30, 2022 | -8.62 Mn |
| Jun 30, 2022 | -9.22 Mn |
| Mar 31, 2022 | -8.78 Mn |
| Dec 31, 2021 | -6.05 Mn |
| Sep 30, 2021 | -6.14 Mn |
| Jun 30, 2021 | -6.20 Mn |
| Mar 31, 2021 | -5.44 Mn |
| Dec 31, 2020 | -6.45 Mn |
| Sep 30, 2020 | -5.62 Mn |
| Jun 30, 2020 | -4.59 Mn |
| Mar 31, 2020 | -4.92 Mn |
| Dec 31, 2019 | -4.38 Mn |
| Sep 30, 2019 | -6.78 Mn |
| Jun 30, 2019 | -5.16 Mn |
| Mar 31, 2019 | -3.44 Mn |
| Dec 31, 2018 | -2.79 Mn |
| Sep 30, 2018 | -2.43 Mn |
| Jun 30, 2018 | -2.84 Mn |
| Mar 31, 2018 | -3.06 Mn |
| Dec 31, 2017 | -2.37 Mn |
| Sep 30, 2017 | -746,000.00 |
| Jun 30, 2017 | -9.69 Mn |
| Mar 31, 2017 | -3.36 Mn |
| Dec 31, 2016 | -11.86 Mn |
| Sep 30, 2016 | -3.41 Mn |
| Jun 30, 2016 | -3.59 Mn |